Skip to content

Treatment protocol for adult acute lymphoblastic leukemia

Treatment protocol for adult acute lymphoblastic leukemia - -ALL/MRD2019-

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs071190036
Enrollment
200
Registered
2019-11-18
Start date
2020-01-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lymphoblastic leukemia

Interventions

Sponsors

Akashi Koichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. acute lymphoblastic leukemia by WHO classification 2. peroxidase positive rate of the blast cell, 3% are less than it 3. The first time treatment example which does not catch chemotherapy or the radiotherapy 4. The case that is equal to or less than 65 years old more than age 16 years old 5. Performance status 0-2 6. A case without the dangerously ill internal organs disorder T.Bil equal to or less than 2.0mg/dL, Cr equal to or less than 2.0mg/dL 7. The case that an agreement by the document is provided from a patient on explanation because of final examination contents

Exclusion criteria

Exclusion criteria: 1. B-ALL(L3) of the blast cell cell surface immune globulin positive 2. A case having double cancers 3. A case with an infectious disease having difficulty with control 4. A case with a severe mental disorder 5. The pregnancy woman 6. the case that the medical attendant judged to be inappropriate

Design outcomes

Primary

MeasureTime frame
3 years disease-free survival

Secondary

MeasureTime frame
3 year, and 5 years overall survival 5 years disease-free survival 3 year, and 5 years CR rate CR rate,MRDneg rate Perfection rate of protocol regimen Treatment related mortality rate Treatment-related toxicities

Contacts

Public ContactKoji Kato

Kyushu University Hospitalism

kato.koji.429@m.kyushu-u.ac.jp+81-92-642-5225

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026